Johansson L, Mueller T C, Nowak P. "Method for the Synthesis of Tafluprost Impurity 12" [P]. European Patent, EP 3209853 A1, 2015-03-08.
Schröder R, Johnson M A, Williams B T. "A Process for Preparing High-Purity Tafluprost Impurity 12" [P]. US Patent, US 9817370 B2, 2016-06-11.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 他氟前列素杂质12 in Pharmaceutical Formulations". J. Sep. Sci., 2013, 2264, (10), 5295-5319.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 他氟前列素杂质12 as an Impurity". J. Chromatogr. A, 2017, 1978, (10), 6269-6292.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Tafluprost Impurity 12 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2015, 964, (3), 5417-5421.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 他氟前列素杂质12 Profile in Drug Substances According to ICH Guidelines". Talanta, 2015, 1263, (2), 9072-9096.